Join Mark Behlke, MD, PhD, Chief Scientific Officer at Integrated DNA Technologies, as he discusses how advances in genomic science are enabling the development of personalized therapies for inherited, acquired, and nano-rare diseases.
The Genomics Revolution has enabled researchers and clinicians to better understand an individual’s genetic makeup and use that information to develop personalized therapies. During this session, Dr Behlke will discuss the key genetic medicine modalities in use today and highlight how these approaches are being applied to tackle rare and nano-rare diseases.
This exclusive lecture will explore the current landscape of genetic medicines and the opportunities ahead for precision healthcare.
“The era of personalized medicine: Exploring the future of genetic medicines”
📅 September 29, 2026
📍 Cancer Research UK Cambridge Institute, University of Cambridge Lecture theatre
Lunch will be provided after the seminar.
Mark Behlke at CRUK 29.9.26 (002)
Posted on 01/09/2026
